Carl Johan Sennbro

Leo Pharma (Denmark) — Denmark

Medicine · Health Sciences

10h-index288citations14works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Occupational exposure and asthma(6), Indoor Air Quality and Microbial Exposure(4), Air Quality and Health Impacts(2), Occupational Health and Safety Research(2), Antibiotics Pharmacokinetics and Efficacy(2)

Publications14 total

Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein–Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
Journal of Medicinal Chemistry·2022· 27 citedOpen Access
Predicting in vivo performance of fenofibrate amorphous solid dispersions using in vitro non-sink dissolution and dissolution permeation setup
International Journal of Pharmaceutics·2021· 14 cited
Quantitative determination of the anti-tumor agent tasquinimod in human urine by liquid chromatography–tandem mass spectrometry
Journal of Chromatography B·2014· 1 cited
Anticoagulant Counter Ion Impact on Bioanalytical LC–MS/MS Assay Performance: Additional Validation Required?
Bioanalysis·2011· 21 cited
Anticoagulant Counter Ion Impact on Bioanalytical LC–MS/MS Assays: Results from Discussions and Experiments Within The European Bioanalysis Forum
Bioanalysis·2011· 21 cited
Development and validation of a method using supported liquid extraction for the simultaneous determination of midazolam and 1′-hydroxy-midazolam in human plasma by liquid chromatography with tandem mass spectrometry detection
Journal of Pharmaceutical and Biomedical Analysis·2011· 23 cited
The GSTP1 Ile105 Val polymorphism modifies the metabolism of toluene di-isocyanate
Pharmacogenetics and Genomics·2010· 25 cited
Determination of the immunomodulator laquinimod in human plasma by liquid chromatography/tandem mass spectrometry; development, validation and application of two methods in clinical pharmacokinetic profiling
Rapid Communications in Mass Spectrometry·2006· 9 cited
Upper reference limits for biomarkers of exposure to aromatic diisocyanates
International Archives of Occupational and Environmental Health·2005· 30 citedOpen Access
Biological and air monitoring of exposure to isocyanates
Lund University Publications (Lund University)·2005
Determination of Isocyanates in Air Using 1-(2-Methoxyphenyl)piperazine-impregnated Filters: Long-term Sampling Performance and Field Comparison with Impingers with Dibutylamine
The Annals of Occupational Hygiene·2004· 25 citedOpen Access
A Survey of Airborne Isocyanate Exposure in 13 Swedish Polyurethane Industries
The Annals of Occupational Hygiene·2004· 39 citedOpen Access
Development, validation and characterization of an analytical method for the quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4- and 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate
Biomarkers·2003· 53 cited
Biological monitoring of toluene diisocyanate (TDI) exposure by analysis of urine from exposed workers
Lund University Publications (Lund University)·2002

Frequent Co-authors

Håkan Tinnerberg(6), Bo Jönsson(6), Christian Lindh(4), Hans Welinder(4), Margareta Littorin(3), G.P. Hansson(2), Leif Svensson(2), Magnus Knutsson(2), Philip Timmerman(2), Peter van Amsterdam(2), Cecilia Gustavsson(1), Anders Östin(1), Mark David Andrews(1), Kevin N. Dack(1), Marcel J. de Groot(1), Maja Lambert(1), Mogens Larsen(1), Martin Stahlhut(1), Karin Bröberg(1), Margareta Warholm(1)